Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
FDNA Expands Facial Analysis Reach to 2,000 Syndromes: New milestone in the fight against rare diseases enables earlier detection and treatment
April 5, 2017
BUSINESS WIRE – “FDNA, a Boston-based digital health company and developer of the Face2Gene suite of applications, is pleased to announce that its facial analysis technology has analyzed facial images of tens of thousands of patients for more than 2,000 different rare genetic diseases. This data is used to recognize associations between facial characteristics and these genetic diseases. This milestone marks a major achievement for a company devoted to ending the lengthy diagnostic journey that accompanies rare diseases.”
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…